
Halitous Pharmaceuticals Private Limited
About Halitous Pharmaceuticals Private Limited
Data last updated:
Halitous Pharmaceuticals Private Limited is a private limited company based in Greater Noida, Uttar Pradesh, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 16 April 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U74993UP2018PTC103203. Its GSTIN is 10AAECH5110K1Z4 (Bihar).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Kumari Diksha and Astha Shanker.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. A – 804 Tower – A Ace City Plot No. Gh – 01 Sector – 1, Greater Noida, Uttar Pradesh, India – 201306.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.58 Lakh, a decline of 32% compared to the previous year. For the same year it recorded a net loss of ₹797 (net margin -0.1%) and EBITDA of -₹797 (EBITDA margin -0.1%). Revenue has declined at a compounded annual rate (CAGR) of 16% over three years and 16% over five years.
Company details
Contact details
Halitous Pharmaceuticals Private Limited's registered office is in Greater Noida, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressFlat No. A – 804 Tower – A Ace City Plot No. Gh – 01 Sector – 1, Greater Noida, Uttar Pradesh, India – 201306
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Halitous Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Halitous Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Halitous Pharmaceuticals Private Limited, buy the company report.
Financials of Halitous Pharmaceuticals Private Limited
FY 2025 filings availableHalitous Pharmaceuticals Private Limited reported revenue of ₹6.58 Lakh (down 32% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 16% over five years, including a 32% fall in the latest year. EBITDA rose 93% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹797 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹797 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.1% | ||||
| Net Profit Margin | -0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Halitous Pharmaceuticals Private Limited, buy the company report.
Board of directors of Halitous Pharmaceuticals Private Limited
Halitous Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kumari Diksha | Director | 01 May 2018 | 8 Years 6 Months | Current |
| Astha Shanker | Director | 16 Apr 2018 | 8 Years 7 Months | Current |
| Mitu Shanker | Director | 16 Apr 2018 | 8 Years 7 Months | Current |
Peer comparison
Halitous Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ratantray Pharmaceuticals Private Limited | ₹6.62 Lakh (FY 2025) | 12.0% | Jaipur, Rajasthan, India | |||
| Venterra Pharmaceuticals Private Limited | ₹6.62 Lakh (FY 2016) | 0.0% | Pune, Maharashtra, India | |||
| Halitous Pharmaceuticals Private Limitedthis company | ₹6.58 Lakh (FY 2025) | -₹797 | -0.1% | -32.0% | Greater Noida, Uttar Pradesh, India | |
| Anthill Pharmaceuticals Private Limited | ₹6.54 Lakh (FY 2018) | Gorakhpur, Uttar Pradesh, India |
To see the full peer comparison of Halitous Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Halitous Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Halitous Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Halitous Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAECH5110K1Z4 | Bihar | Active | 30 Jul 2018 |
To see the full GST registrations and return filing status of Halitous Pharmaceuticals Private Limited, buy the company report.
Recent activity
Halitous Pharmaceuticals Private Limited has 4 board changes on record since 2018: 3 appointments and 1 cessation. The latest: Monika ceased to be Director on 17 May 2022.
Frequently asked questions
Halitous Pharmaceuticals is an active private limited company based in Greater Noida, Uttar Pradesh, India. The company works in other services, within the business services industry. It was incorporated on 16 April 2018 (8+ years old) and is registered under CIN U74993UP2018PTC103203.
Halitous Pharmaceuticals has 3 current directors:
- Kumari Diksha - Director
- Astha Shanker - Director
- Mitu Shanker - Director
The latest financial statements of Halitous Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Halitous Pharmaceuticals is 10AAECH5110K1Z4, registered in Bihar.
The CIN (Corporate Identification Number) of Halitous Pharmaceuticals is U74993UP2018PTC103203. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Halitous Pharmaceuticals was incorporated on 16 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Halitous Pharmaceuticals by revenue are Ratantray Pharmaceuticals Private Limited, Venterra Pharmaceuticals Private Limited, Anthill Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Monika ceased to be Director on 17 May 2022. Kumari Diksha was appointed as Director on 01 May 2018. Astha Shanker was appointed as Director on 16 Apr 2018. Halitous Pharmaceuticals has 4 board changes on record in total.
The registered office of Halitous Pharmaceuticals is at Flat No. A – 804 Tower – A Ace City Plot No. Gh – 01 Sector – 1, Greater Noida, Uttar Pradesh, India – 201306.
Halitous Pharmaceuticals operates in the business services industry, in the other services segment.
Halitous Pharmaceuticals can be reached at its registered office: Flat No. A – 804 Tower – A Ace City Plot No. Gh – 01 Sector – 1, Greater Noida, Uttar Pradesh, India – 201306.

